What does Sabra Health Care REIT do?
Sabra Health Care REIT, Inc. is a self-administered healthcare REIT listed on Nasdaq as SBRA. It owns and finances healthcare properties in the United States and Canada, with the largest exposure to skilled nursing and senior housing. Sabra usually supplies real estate capital and selects operators rather than delivering care itself.
What is in the portfolio?
At March 31, 2026, the official portfolio overview showed 208 skilled nursing or transitional care facilities, 32 leased senior housing communities, 90 managed senior housing communities, 16 behavioral health facilities, and 15 specialty hospitals and other facilities. It also included 13 loans, five preferred equity investments, and two unconsolidated joint ventures.
Who uses the assets, and where are they located?
Sabra primarily works with regional operators. Texas was the largest state at 56 properties, or 15.5% of the consolidated portfolio, followed by California at 29 and Kentucky at 28. The footprint reached 37 other U.S. states and Canada, while the largest relationship contributed 7.8% of annualized Cash NOI.
How does Sabra make money across triple-net leases and managed senior housing?
Sabra uses three economic models: contractual rent from triple-net leases, resident fees less property expenses from managed senior housing, and interest or preferred returns from structured investments. Each offers a different mix of predictability, upside, capital needs, and operating risk.
Why are triple-net leases the stable base?
Under triple-net leases, operators generally pay taxes, insurance, maintenance, and facility costs in addition to rent. Sabra gains revenue visibility but retains tenant-credit risk. Latest coverage was 2.46 times for skilled nursing, 1.58 times for leased senior housing, and 4.00 times for behavioral health, specialty hospitals, and other facilities.
Why is managed senior housing the growth engine?
Managed senior housing carries more operating leverage because Sabra records resident fees and property expenses. Occupancy, REVPOR, labor, insurance, and local competition flow directly into Cash NOI. In Q1 2026, same-store managed Cash NOI rose 14.4% and margin reached 32.3%, illustrating the upside when occupancy and pricing improve.
What do loans and preferred equity add?
Loans and preferred equity expand Sabra’s capital solutions. At March 31, 2026, 13 loans had $374.0 million of principal at a 7.7% weighted average contractual rate, while five preferred equity investments had $51.8 million funded at an 11.0% stated return. These structures add credit, construction, and collateral risk.
| Revenue model | Q1 2026 evidence | Primary driver | Main risk |
|---|---|---|---|
| Rental and related revenue | $95.1M | Contract rent, escalators, lease terms, and operator solvency | Tenant distress, reimbursement pressure, or operator transition |
| Resident fees and services | $116.7M | Occupancy, REVPOR, community mix, and cost control | Labor inflation, weak demand, or management execution |
| Interest and other income | $10.0M | Loan balances, contractual yields, and preferred returns | Credit loss, delayed development, or collateral impairment |
Which portfolio categories drive Cash NOI?
Sabra reports one GAAP operating segment, so property type is the more informative economic view. At March 31, 2026, skilled nursing remained the largest Annualized Cash NOI source, while managed senior housing had become a substantial second pillar.
What does the mix reveal about strategic tension?
Skilled nursing brings reimbursement, labor, litigation, and regulatory exposure. Managed senior housing adds private-pay demand and stronger operating upside, but also more volatility and capital spending. Sabra’s central trade-off is therefore contractual rent stability versus managed-property operating leverage.
How concentrated are relationships and leases?
The five largest named relationships generated roughly one-third of Annualized Cash NOI, and the largest, The Ensign Group, represented 7.8%. Lease expirations were limited to 2.2% of triple-net annualized revenue for the rest of 2026 and 3.1% in 2027; the weighted average remaining term was about seven years.
What do the latest Q1 2026 results and May business update show?
Sabra’s first-quarter 2026 earnings release showed revenue rising 20.8% to $221.8 million, led by the expanded managed senior housing platform. Net income attributable to Sabra was nearly flat at $40.9 million as property operating costs, depreciation, interest, and corporate expenses also increased.
What changed in the quarter?
| Metric | Q1 2026 | Q1 2025 | Interpretation |
|---|---|---|---|
| Total revenue | $221.8M | $183.5M | Growth was led by resident fees and services. |
| Resident fees and services | $116.7M | $77.4M | A 50.7% increase reflecting acquisitions and improved managed-community economics. |
| Net income attributable to Sabra | $40.9M | $40.3M | Higher property earnings were offset by a larger expense base. |
| Normalized FFO per share | $0.38 | $0.35 | Core REIT earnings advanced despite a higher diluted share count. |
| Operating cash flow | $98.4M | $80.3M | Cash generation increased 22.5% year over year. |
Why is managed senior housing the clearest operating signal?
For 65 same-store properties, occupancy rose to 88.4% from 85.6%, REVPOR increased to $4,755 from $4,547, and Cash NOI reached $23.5 million from $20.5 million. Margin improved to 32.3% from 30.4%, confirming organic improvement beyond acquisitions. Reconciliations appear in the Q1 2026 supplemental package.
What did the May 28 update add?
The May 28, 2026 investor presentation reported $277 million of closed investments at a 7.9% initial cash yield and nearly $410 million awarded at 6.8%. Sabra also sold three skilled nursing properties for $79 million at a 6.8% lease yield. Funding spreads now matter as much as acquisition volume.
Which turning points shaped Sabra’s strategy?
Sabra’s history explains its emphasis on operator selection, multiple deal structures, concentration limits, and balance-sheet flexibility: the company began with a concentrated predecessor relationship and diversified deliberately.
From spin-off landlord to diversified healthcare capital platform
-
2010Sabra began operating as a separate public REIT on November 15 after Sun Healthcare separated its real estate and operations. The concentrated tenant base made diversification urgent.
-
2011Acquisitions accelerated, including $171.5 million announced with second-quarter results, while Sun exposure fell to 79%. Repeat operator relationships became an origination tool.
-
2017The Care Capital Properties combination expanded scale, operator diversity, and capital access. The official merger registration statement described a larger healthcare REIT platform.
-
2020The pandemic exposed the reimbursement, labor, and occupancy sensitivity of skilled nursing and senior housing, elevating liquidity and operator support.
-
2022–2024More than $70 million was invested to modernize managed communities, supporting later occupancy and margin recovery.
-
2025Real estate acquisitions reached $452.9 million and revenue rose to $774.6 million, shifting the mix further toward managed senior housing.
-
2026By May 28, Sabra had closed $277 million and secured nearly $410 million of awarded investments. Funding and integration replaced recovery as the main execution test.
What gives Sabra a competitive advantage?
Sabra’s advantage is institutional rather than technological: healthcare operating experience, public-market capital, regional operator relationships, flexible structures, and the ability to evaluate both property and care-delivery economics. Former-operator experience is central to its stated positioning.
Why does operator underwriting matter?
Healthcare properties are specialized and regulated, so replacing a weak tenant can require licensing, working capital, staff retention, and physical investment. Sabra’s underwriting and transition capabilities create a practical barrier to entry. Aggregate triple-net coverage improved to 2.62 times for the year ended December 31, 2025, from 2.55 times at September 30, 2025.
Who are the main competitors?
Sabra competes with healthcare REITs, private funds, banks, and specialty lenders. Public peers include Omega Healthcare Investors, CareTrust REIT, National Health Investors, LTC Properties, American Healthcare REIT, Ventas, and Welltower. Omega and CareTrust lean more toward skilled nursing; Ventas and Welltower have broader senior housing platforms.
| Competitive dimension | Sabra position | Why it matters |
|---|---|---|
| Skilled nursing exposure | 47.1% of Annualized Cash NOI, March 31, 2026 | Meaningful expertise and yield, offset by reimbursement and operator-credit sensitivity. |
| Senior housing exposure | 35.9% managed plus leased Cash NOI | Adds private-pay growth and operating leverage relative to pure SNF landlords. |
| Largest relationship | 7.8% | Lower concentration than many landlord models reduces single-operator shock. |
| Capital structure flexibility | Leases, managed assets, loans, preferred equity, and JVs | Allows Sabra to compete for deals across the capital stack. |
How strong are the balance sheet, cash flow, and dividend?
At March 31, 2026, Sabra had $2.69 billion of consolidated debt, $116.5 million of cash, about $1.2 billion of liquidity, and investment-grade unsecured ratings. For a REIT, leverage, coverage, maturities, secured borrowing, and access to equity are more informative than cash alone.
What does the credit profile show?
| Credit metric | March 31, 2026 | Assessment |
|---|---|---|
| Net debt / adjusted EBITDA | 5.04x | Near management’s long-run leverage objective; not low, but manageable for an investment-grade REIT. |
| Interest coverage | 4.59x | Provides a meaningful earnings cushion over interest expense. |
| Fixed-charge coverage | 4.51x | Supports debt service and preferred fixed obligations. |
| Secured debt / asset value | 1% | Most assets remain unencumbered, preserving financing flexibility. |
| Weighted average debt rate | 4.02% | Below many current acquisition yields, though refinancing can raise future costs. |
| Weighted average maturity | 3.8 years | Moderate duration; no material maturity wall until 2028 after extension assumptions. |
Although 51.8% of debt was classified as variable rate, swaps fixed $930.0 million of SOFR debt at 3.20% and CAD 150.0 million at 2.59%. Only 13.2% was effectively unhedged variable debt. The full schedule is in the March 31, 2026 Form 10-Q.
How sustainable is capital allocation?
In 2025, operating cash flow was $348.6 million, normalized AFFO was $365.4 million, and cash dividends were $289.5 million, about 79% of AFFO. Q1 2026 dividends of $75.7 million were roughly 75% of $100.6 million of normalized AFFO. The quarterly dividend remained $0.30 per share; see the official dividend history.
| Capital use | FY2025 | Q1 2026 | Interpretation |
|---|---|---|---|
| Operating cash flow | $348.6M | $98.4M | Core cash generation supports dividends and recurring investment needs. |
| Real estate acquisitions | $452.9M | $96.1M | Growth requires external capital as well as retained cash. |
| Additions to real estate | $41.5M | $11.9M | Property quality and managed-community performance depend on continued investment. |
| Common dividends paid | $289.5M | $75.7M | A substantial cash commitment, but currently covered by normalized AFFO. |
| Common equity issued, net | $227.8M | $(8.2)M | ATM and forward equity are key match-funding tools; settlement timing can shift cash flow between periods. |
The 2025 Form 10-K recorded $187.0 million of real estate depreciation, showing why GAAP net income is incomplete for REIT analysis. FFO and AFFO are useful, but recurring capital needs and dilution still matter.
Who owns Sabra stock, and how is it governed?
Sabra has one common share class with one vote per share and no controlling founder block. The 2026 proxy listed BlackRock, Vanguard, and Principal Real Estate Investors above 5%; their combined reported stake was about 35.7%, giving institutional stewardship policies meaningful influence.
Which holders have the largest economic stakes?
| Holder or group | Reported shares | Reported stake | Why it matters |
|---|---|---|---|
| BlackRock, Inc. | 34,468,209 | 13.67% | Large passive and institutional voting presence. |
| The Vanguard Group | 34,133,957 | 13.54% | Broad index ownership links governance to institutional stewardship policies. |
| Principal Real Estate Investors | 21,331,583 | 8.46% | A specialist real estate investor with a meaningful economic stake. |
| Directors and executive officers as a group | 2,748,858 | 1.09% | Management has economic alignment, but no controlling insider block. |
The values come from the 2026 proxy statement; holder dates differ because the table uses each institution’s Schedule 13G filing.
How is leadership oversight structured?
Rick Matros has served as CEO and director since 2010 and also chairs the board. Lead independent director Michael Foster provides a formal counterweight. Six of the seven directors listed in the Q1 2026 supplemental were non-management. Oversight of leverage, executive incentives, operator decisions, and succession is therefore the central governance test.
What opportunities, risks, and KPIs matter most?
The growth case combines aging demographics, limited new supply, occupancy recovery, operator expansion, and acquisitions above the cost of capital. Management cited expected growth above 4% annually in the U.S. population over age 80 through 2040. Demand can support pricing, but reimbursement, labor, execution, and funding risks remain.
Which risks could change the story fastest?
| Risk | Financial transmission | Metric to monitor |
|---|---|---|
| Government reimbursement pressure | Weakens skilled nursing operator margins and rent coverage. | SNF EBITDARM coverage, cash rent collections, tenant restructurings |
| Labor inflation and shortages | Raises managed-property expenses and pressures tenants. | Cash NOI margin, agency labor use, same-store expense growth |
| Interest rates and equity-market volatility | Raises debt and equity costs, compressing acquisition spreads. | Weighted debt rate, ATM price, acquisition yield, leverage |
| Acquisition and integration risk | Unstabilized communities may require more capital and time than underwritten. | Occupancy ramp, nonrecurring capex, acquired-property NOI |
| Real estate impairment or operator failure | Creates write-downs, lost rent, transition costs, or asset sales below carrying value. | Impairments, assets held for sale, loan-loss allowance |
| REIT and regulatory compliance | Limits retained taxable income and adds healthcare licensing, privacy, and environmental obligations. | Distribution coverage, compliance disclosures, regulatory transfer timing |
What is the key takeaway for valuation?
Sabra is a hybrid healthcare REIT, not a simple bond substitute. Triple-net rent supplies stability, while managed senior housing contributes meaningful Cash NOI and operating growth. A DCF or NAV analysis should separate leased cash flows, managed NOI, structured investments, corporate costs, recurring capital expenditures, and financing.
Key DCF inputs are AFFO growth, same-store managed NOI, acquisition yield and volume, recurring capital needs, share issuance, leverage, and the terminal discount rate. Comparable analysis adds FFO or AFFO multiples, dividend yield, skilled nursing concentration, tenant coverage, and discount or premium to NAV. No single metric captures both cash generation and risk.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
